News & Updates
Filter by Specialty:
TNFi use carries only modest increase in psoriasis risk
The use of tumour necrosis factor-α inhibitor (TNFi) for inflammatory bowel disease (IBD) or rheumatoid arthritis (RA) raises the risk of developing psoriasis by twofold as compared with conventional therapy, although the absolute risk remains modest, as reported in a study.
TNFi use carries only modest increase in psoriasis risk
04 Jul 2022
Statins reduce death, mechanical ventilation use in hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who are treated with statins are less likely to undergo invasive mechanical ventilation or die, according to the results of a multicentre study in the US.
Statins reduce death, mechanical ventilation use in hospitalized COVID-19 patients
04 Jul 2022
Gout patients endorse reasons for not taking allopurinol
Patients with gout who refuse to take allopurinol for their condition do so because of their desire to lead a normal life and to test whether they could reduce the dose without experiencing any symptoms, a recent study has found.
Gout patients endorse reasons for not taking allopurinol
02 Jul 2022
Thromboxane generation tied to mortality regardless of aspirin use
Systemic thromboxane generation appears to increase the risk of all-cause and cardiovascular mortality regardless of aspirin use, reveals a study. Hence, its measurement may help inform therapy modification, especially in individuals without cardiovascular disease (CVD).
